A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 171
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : Gy
Long Form : grays
No. Year Title Co-occurring Abbreviation
2019 Functional outcomes of the modified submandibular gland transfer procedure. M-SGT, RT, SMG, ST, UW-QOL
2019 Impact of hypofractionated schemes in radiotherapy for locally advanced head and neck cancer patients. CTV-PTV, DFS, LAHNC, LRC, OS
2019 Patient-reported versus physiologic swallowing outcomes in patients with head and neck cancer after chemoradiation. DIGEST, HNC, MDADI
2019 Thyroid Cancer after Exposure to Radioiodine in Childhood and Adolescence: 131I-Related Risk and the Role of Selected Host and Environmental Factors. ---
2018 Follicular lymphoma presenting as scalp mass deformity: Case Report and Review of the literature. FL
2017 Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques. CCRT, CIs, IMRT, RT, TESCC
2017 Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy. IMRT, ORN
2017 Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base. ATC, CI, HR, MVA, NCDB, OS, RT
2016 Acute Toxicity of Gamma Radiation to the Monogonont Rotifer Brachionus koreanus. LD50-24h
10  2016 Intensity-modulated radiotherapy reduces toxicity with similar biochemical control compared with 3-dimensional conformal radiotherapy for prostate cancer: A randomized clinical trial. 3DCRT, GI, GU, IMRT
11  2016 PMH 9907: Long-term outcomes of a randomized phase 3 study of short-term bicalutamide hormone therapy and dose-escalated external-beam radiation therapy for localized prostate cancer. BF, DE-EBRT, HT, IRPC, LC, LPC, OS
12  2014 Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. EPIC, IMRT, PROSTQA, PT, QOL
13  2014 Extreme heterogeneity of myeloablative total body irradiation techniques in clinical practice: a survey of the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation. LINAC, TBI
14  2014 Role of concomitant chemoradiation in locally advanced head and neck cancers. ---
15  2013 Intensity-modulated radiotherapy (IMRT) in pediatric low-grade glioma. CTV, GTV, IMRT, LGG
16  2013 Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer. MPLC, OS, PFS, SABR
17  2013 The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer. ADT, BF, CI, CMRT, EBRT, HiRPCa, HRs, PCSM, RT
18  2013 The influence of adjuvant radiotherapy dose on overall survival in patients with resected pancreatic adenocarcinoma. A-RT, HR, NCDB, OS, PAC
19  2012 A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors. PCI, RT
20  2012 Dose-escalation of whole-brain radiotherapy for brain metastasis in patients with a favorable survival prognosis. LC, OS, WBRT
21  2012 Hearing preservation in patients with unilateral vestibular schwannoma who undergo stereotactic radiosurgery: Reinterpretation of the auditory brainstem response. dB, IL, mS, PTA, SRS, VS
22  2012 Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial. AUA, bPFS, EPIC, PSA, SHIM
23  2012 Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG. NPC
24  2012 Stereotactic body radiotherapy using a radiobiology-based regimen for stage I nonsmall cell lung cancer: a multicenter study. SBRT
25  2012 Stereotactic radiosurgery of World Health Organization grade II and III intracranial meningiomas: treatment results on the basis of a 22-year experience. DSS, EBRT, HR, PFS, SRS, WHO
26  2011 Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapy: single-Institution Experience in 600 Patients. KPS, MFS, OS, PFS
27  2011 Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809. ADT, ASTRO, DFS, EBRT
28  2011 Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence. PSA
29  2011 Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: a prospective study with >5 years of follow-up. IMRT, MID, NPC, SOMA, TMJ
30  2011 Local control after craniospinal irradiation, intensity-modulated radiotherapy boost, and chemotherapy in childhood medulloblastoma. CSI, IMRT, PF, TB
31  2011 Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. BED, IMRT, NPC, SMART
32  2011 Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance. HNSCC, OR
33  2011 Prospective evaluation of spinal reirradiation by using stereotactic body radiation therapy: The University of Texas MD Anderson Cancer Center experience. ---
34  2011 Solitary plasmacytomas: outcome and prognostic factors after definitive radiation therapy. MM, SP
35  2011 Thoracic radiation therapy improves the overall survival of patients with extensive-stage small cell lung cancer with distant metastasis. CE, CHT, OS, TRT
36  2010 Breast-conserving therapy after previous irradiation for lymphoma. RT
37  2010 Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy. HL
38  2010 Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme. PFS
39  2010 Efficacy of radiotherapy for painful bone metastases during the last 12 weeks of life: results from the Dutch Bone Metastasis Study. ---
40  2010 Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. DFS, MALT, OS, RFR, RT
41  2010 Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer. LAEC
42  2010 Prediction of pathologic fracture risk of the femur after combined modality treatment of soft tissue sarcoma of the thigh. STS
43  2010 Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial. CA, EA, FFTF, HCG, HL
44  2010 Spinal cord sparing reirradiation with helical tomotherapy. CT
45  2010 Toxicity report of a phase 1/2 dose-escalation study in patients with inoperable, locally advanced nonsmall cell lung cancer with helical tomotherapy and concurrent chemotherapy. DC, HT, MTD
46  2009 Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy. EBRT, HCC, KPS
47  2009 Hypofractionated stereotactic radiotherapy for the treatment of brain metastases. HSRT, SRS
48  2009 Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. iSUV
49  2009 Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. CRT, NSCLC, RT
50  2009 Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy. COPD, CT, SRT
51  2009 Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy. 3D-CRT, BRT, EBRT, GI, GU, IMRT, Pd-103, RTOG
52  2009 Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation. NF2
53  2009 Radiotherapy in adrenocortical carcinoma. ACC
54  2008 Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results. CRT, MRI, RD
55  2008 From conventionally fractionated radiation therapy to hyperfractionated radiation therapy alone and with concurrent chemotherapy in patients with early-stage nonsmall cell lung cancer. CF, NSCLC, RT
56  2008 Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation. PCI, SCLC
57  2008 Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases. NSCLC, TMZ, WBRT
58  2008 Stereotactic radiosurgical treatment of brain metastases in older patients. SRS
59  2008 The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. ASTRO, BF, CSM, DM, OM, RT
60  2007 A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. BC, LC, OS, RPA, RR, WBRT
61  2007 A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. BED, CNS, FFP, RT
62  2007 Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. FSRT
63  2007 Childhood intracranial ependymoma: twenty-year experience from a single institution. CHOP, HUP, OS, PFS
64  2007 Dose escalation beyond 30 grays in 10 fractions for patients with multiple brain metastases. KPS, RPA, WBRT
65  2007 Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients. KPS, RPA, RR, WBRT
66  2007 High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy. ASCT, HDC, PF
67  2007 Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. BC, LC, OS, RPA, RR, SRS, WBRT
68  2007 The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. FRT, SRS
69  2007 The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. IBT
70  2007 Whole-brain radiotherapy versus stereotactic radiosurgery for patients in recursive partitioning analysis classes 1 and 2 with 1 to 3 brain metastases. BC, DC, KPS, LC, OS, RPA, RR, SRS, WBRT
71  2006 Clinical outcomes of single-fraction stereotactic radiation therapy of lung tumors. LPFRs, SRT
72  2006 Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. ---
73  2006 Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters. CR, DFS, LCP, NK, OAS, RT
74  2006 Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. CT, RPSs
75  2006 Proton beam therapy for hepatocellular carcinoma with limited treatment options. HCC
76  2006 Radiosurgery for the treatment of spinal lung metastases. ---
77  2006 Results of postoperative reirradiation for recurrent or second primary head and neck carcinoma. PRI-PORT, RE-PORT
78  2006 Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer. CHART, NSCLC
79  2005 A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma. QOL, RCC, RT
80  2005 Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. AJCC, DFS, OS, pathCR
81  2005 Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer. A phase II trial conducted by the Groupe Francais de Pneumo-Cancerologie (GFPC). CT-RT, GFPC, NSCLC
82  2005 Dosimetric parameters that predict late rectal complications after curative radiotherapy in patients with uterine cervical carcinoma. BED, EBRT, HDR-ICR, LRC
83  2005 Epoetin-alpha during radiotherapy for stage III esophageal carcinoma. LC, MFS, OS, RT
84  2005 High-dose-rate brachytherapy as part of a multidisciplinary treatment of nasopharyngeal lymphoepithelioma in childhood. ---
85  2005 Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma. HYPERRADPLAT
86  2005 Nasopharyngeal intracavitary brachytherapy: the controversy of T2b disease. ERT, HDR, NPC
87  2005 Programmed cell death as a prognostic indicator for radiation therapy in cervical carcinoma patients: a pilot study. AI, DMEM, MF, TUNEL
88  2005 Radiation-induced sarcomas after radiotherapy for breast carcinoma: a large-scale single-institution review. RIS
89  2005 Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. MTD, NSCLC, NTCP
90  2005 Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. ---
91  2004 Accumulation of Mn(II) in Deinococcus radiodurans facilitates gamma-radiation resistance. ---
92  2004 Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma. CS, EIC, IBTR, RT
93  2004 Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid. DHA, NMU, ROS
94  2004 Inflammatory breast carcinoma: outcomes with trimodality therapy for nonmetastatic disease. IBC
95  2004 Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. IMRT, NPC, RT, SPS, SWS
96  2004 Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma. EBRT, PTC
97  2004 Recurrence-free survival rates after external-beam radiotherapy for patients with clinical T1-T3 prostate carcinoma in the prostate-specific antigen era: what should we expect? AD, BRFS, RT
98  2004 Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme. CYC, PFS
99  2004 The role of craniospinal irradiation in adults with a central nervous system recurrence of leukemia. ALL, AML, CNS, CSF, CSI
100  2004 Therapy of meningeal melanocytomas. CTR, CTR-RT, ITR, ITR-RT